|
CENPO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.117400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.495920E-02 |
| Normal-vs-Stage2 |
9.862400E-01 |
| Normal-vs-Stage3 |
1.267560E-01 |
| Normal-vs-Stage4 |
2.658400E-01 |
| Stage1-vs-Stage2 |
1.214190E-01 |
| Stage1-vs-Stage3 |
6.398700E-03 |
| Stage1-vs-Stage4 |
8.643000E-01 |
| Stage2-vs-Stage3 |
2.245600E-01 |
| Stage2-vs-Stage4 |
2.914200E-01 |
| Stage3-vs-Stage4 |
7.889700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.948600E-01 |
| Normal-vs-AfricanAmerican |
1.953970E-01 |
| Normal-vs-Asian |
6.452200E-01 |
| Caucasian-vs-AfricanAmerican |
6.435800E-01 |
| Caucasian-vs-Asian |
9.921400E-01 |
| AfricanAmerican-vs-Asian |
8.503000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.220400E-02 |
| Normal-vs-Female |
1.297370E-01 |
| Male-vs-Female |
2.987800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.825400E-01 |
| Normal-vs-Extreme_Weight |
6.823200E-03 |
| Normal-vs-Obese |
9.127400E-01 |
| Normal-vs-Extreme_Obese |
1.062360E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.334600E-01 |
| Normal_Weight-vs-Obese |
3.991600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.183400E-01 |
| Extreme_Weight-vs-Obese |
1.420430E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.533200E-01 |
| Obese-vs-Extreme_Obese |
1.184000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.839380E-01 |
| Normal-vs-Age(41-60Yrs) |
8.981800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.179800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.556620E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.362840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.499510E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.623000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.992300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.382000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.802200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.374400E-02 |
| Normal-VS-Type2 PRCC |
2.570200E-01 |
| Normal-VS-KIRP CIMP |
1.040420E-01 |
| Normal-VS-Unclassified PRCC |
1.702830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.261000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.366100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.002700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.098300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.533700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.853630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.272970E-01 |
| Normal-vs-N1 |
8.394400E-02 |
| Normal-vs-N2 |
9.533000E-01 |
| N0-vs-N1 |
1.846250E-02 |
| N0-vs-N2 |
4.999800E-01 |
| N1-vs-N2 |
4.959400E-01 |
|
|
